Boston Scientific (BSX) Tops Q3 EPS by 1c

Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.86 billion.

Boston Scientific sees Q4 2015 EPS of $0.23-$0.25, versus the consensus of $0.26. Boston Scientific sees Q4 2015 revenue of $1.97-2.01 billion, versus the consensus of $2.00 billion.

Boston Scientific sees FY2015 EPS of $0.90-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue of $7.47-7.51 billion, versus prior guidance of $7.275-7.375 billion and the consensus of $7.48 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Centene (CNC) PT Raised to $75 at Cantor Fitzgerald After Management Call, Checks
• Macquarie Downgrades Orora Ltd. (ORA:AU) (ORRAF) to Neutral